IRS2


Summary: This gene encodes the insulin receptor substrate 2, a cytoplasmic signaling molecule that mediates effects of insulin, insulin-like growth factor 1, and other cytokines by acting as a molecular adaptor between diverse receptor tyrosine kinases and downstream effectors. The product of this gene is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation, as well as by an interleukin 4 receptor-associated kinase in response to IL4 treatment. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location
OMIM IDMIM:600797
PHARMGKB IDPA375
Map Location13q34

GO terms in IRS2


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
CC IBA GO:0005829 cytosol
CC TAS GO:0005829 cytosol
CC IBA GO:0005886 plasma membrane
CC TAS GO:0005886 plasma membrane
CC IEA GO:0032991 protein-containing complex
BP TAS GO:0000165 MAPK cascade
Showing 1 to 6 of 48 rows rows per page

Gene expression in normal tissue: IRS2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

undefined6PI3K/MTOR signaling1Mitosis1Proteasome1Other, kinases1

Pathways in IRS2


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-109704 PI3K Cascade
reactome R-HSA-112399 IRS-mediated signalling
reactome R-HSA-112399 IRS-mediated signalling
reactome R-HSA-112412 SOS-mediated signalling
reactome R-HSA-112412 SOS-mediated signalling
reactome R-HSA-1257604 PIP3 activates AKT signaling
Showing 1 to 6 of 92 rows rows per page

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD414 MST-312 3
iGMDRD506 Fedratinib 6
iGMDRD780 PP-30 1
iGMDRD152 179324-69-7 6
Showing 1 to 4 of 10 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in IRS2

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​